Efficacy of Interferon α-2b and Ribavirin against West Nile Virus In Vitro
Open Access
- 1 January 2002
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 8 (1) , 107-108
- https://doi.org/10.3201/eid0801.010252
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Ribavirin Inhibits West Nile Virus Replication and Cytopathic Effect in Neural CellsThe Journal of Infectious Diseases, 2000
- Origin of the West Nile Virus Responsible for an Outbreak of Encephalitis in the Northeastern United StatesScience, 1999
- Isolation of West Nile Virus from Mosquitoes, Crows, and a Cooper's Hawk in ConnecticutScience, 1999
- Ribavirin and interferon alfa‐2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactionsBritish Journal of Clinical Pharmacology, 1998
- Different pathogenicity of encephalitic togaviruses in organotypic cultures of spinal cord slicesJournal of Neuroscience Research, 1990
- Ribavirin disposition in high-risk patients for acquired immunodeficiency syndromeClinical Pharmacology & Therapeutics, 1987